VectraCor’s technology incorporates the world’s first patented “Cardiac Electrical Biomarker” (CEB) for the real-time detection of ECG changes suggestive of an AMI. The VectraplexECG System needs only 5 electrodes (Limbs and V2) to derive a 15-lead ECG in the US and 22 lead ECG in the EU (CE Mark/MDR). The CEB will be displayed on the ECG machine as a number in real-time, in the same manner as the heart rate. CEB may change if the patient begins to develop ECG changes suggestive of an AMI, an internal and audible alarm will go off. The VectraplexECG can also produce the standard 12 lead ECG with 10 electrodes.